rs372754256
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002016.2(FLG):c.7031C>G(p.Ser2344*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000258 in 1,613,232 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_002016.2 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 151592Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.000467 AC: 117AN: 250512Hom.: 0 AF XY: 0.000568 AC XY: 77AN XY: 135618
GnomAD4 exome AF: 0.000270 AC: 394AN: 1461524Hom.: 0 Cov.: 58 AF XY: 0.000356 AC XY: 259AN XY: 727022
GnomAD4 genome AF: 0.000152 AC: 23AN: 151708Hom.: 0 Cov.: 28 AF XY: 0.000243 AC XY: 18AN XY: 74156
ClinVar
Submissions by phenotype
Ichthyosis vulgaris Pathogenic:4
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.047%). Stop-gained (nonsense): predicted to result in a loss or disruption of normal protein function through protein truncation. The predicted truncated protein may be shortened by more than 10%. The variant has been reported at least twice as pathogenic without evidence for the classification (ClinVar ID: VCV000522001 / PMID: 29056476). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
- -
The stop gained variant c.7031C>G (p.Ser2344Ter) in the FLG gene has been reported in an individual affected with Ichthyosis vulgaris (Wong et al., 2018). The variant has 0.04% allele frequency in gnomAD Exomes. This variant has been reported to the ClinVar database as Pathogenic/ Likely pathogenic. However, study on multiple affected individuals and functional studies on the pathogenicity of the variant is unavailable. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease-causing (Smith et al., 2006). For these reasons, this variant has been classified as Likely Pathogenic. -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
Identified in individuals with atopic dermatitis; several of these individuals also had other variants in the FLG gene (PMID: 37067103, 29056476); Nonsense variant predicted to result in protein truncation, as the last 1718 amino acids are lost, and other loss-of-function variants have been reported downstream in HGMD; This variant is associated with the following publications: (PMID: 37200867, 37067103, 29056476) -
Dermatitis, atopic, 2 Pathogenic:1
This sequence variant is a single nucleotide substitution (C>G) at coding position 7031 of the FLG gene that generates a premature stop codon at serine 2344 of the FLG protein. This variant is predicted to generate a non-functiol allele through either the expression of a truncated protein or by nonsense mediated decay. This variant was observed by NGS and confirmed with Sanger sequencing. However, due to the presence of several large homologous repeats within FLG, the termition codon may not reside in the exact location listed above. This is a previously reported variant (ClinVar) that has been observed in the literature in individuals with atopic dermatitis (PMID: 29056476). This variant is present in control population datasets (gnomAD database 117 of 250512 alleles or 0.047%). Because haploinsufficiency is a known mechanism of disease for FLG, we consider this variant to be likely pathogenic. ACMG Criteria: PP3, PVS1 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at